Enzyme Inhibition and Regulation

Enzyme inhibition occurs when a molecule reduces the catalytic activity of an enzyme. Inhibitors are particularly important in pharmacology because many therapeutic compounds act by selectively targeting enzymes involved in disease-associated processes.

In classical reversible inhibition, three major mechanisms are commonly distinguished:

• Competitive inhibition: The inhibitor competes with the substrate for binding to the active site. In the classical Michaelis–Menten model, apparent Km increases while Vmax remains unchanged.
• Pure noncompetitive inhibition: The inhibitor binds to the enzyme and enzyme-substrate complex with equal affinity. Vmax decreases, while Km remains unchanged.
• Uncompetitive inhibition: The inhibitor binds preferentially to the enzyme-substrate complex. Both apparent Km and Vmax decrease.

Mixed inhibition is another important mechanism in which inhibitor binding affects substrate interaction and catalytic activity unequally.

Enzymes can also be regulated through allosteric interactions, covalent modifications such as phosphorylation, proteolytic activation, and changes in gene expression. These mechanisms allow cells to coordinate metabolic activity with energy availability, environmental conditions, and physiological requirements.